Figures & data
Table I. Clinical characteristics among breast cancer patients in Sweden: the study sample vs. non-approached eligible patients (n = 568) and approached eligible patients not included in the analyses (n = 487a).
Table II. Comparisons between the study sample of breast cancer patients in Sweden and normative data from the general Swedish female population adjusting for age (EORTC QLQ-C30: ≤ 79 years; HADS: 30–59 years).
Table III. Clinically meaningful mean group differences based on fully adjusteda regression models of EORTC functioning scales (study sample: breast cancer patients in Sweden).
Table IV. Clinically meaningful mean group differences based on fully adjusteda regression models of EORTC symptom scales (study sample: breast cancer patients in Sweden).
Table V. Clinically meaningful mean group differences based on fully adjusteda regression models of the HADS (study sample: breast cancer patients in Sweden).